Connect Biopharma Holdings Ltd. (CNTB)
0.8022
-0.03
(-3.97%)
USD |
NASDAQ |
Oct 30, 16:00
0.80
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Cash from Investing (Quarterly) : -4.456M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.456M |
| March 31, 2026 | 6.00M |
| December 31, 2025 | 11.13M |
| Date | Value |
|---|---|
| September 30, 2025 | 14.38M |
| June 30, 2025 | 5.083M |
| March 31, 2025 | -20.64M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 0.00 |
| Vaxcyte, Inc. | 147.72M |
| Foghorn Therapeutics, Inc. | -2.967M |
| Caribou Biosciences, Inc. | 18.94M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.19M |
| Cash from Financing (Quarterly) | 1.484M |
| Free Cash Flow | -61.54M |
| Free Cash Flow Per Share (Quarterly) | -0.2574 |
| Free Cash Flow to Equity (Quarterly) | -16.09M |
| Free Cash Flow to Firm (Quarterly) | -16.19M |
| Free Cash Flow Yield | -132.7% |